US Approves AstraZeneca’s Zurampic Gout Drug

05.01.2016 - Swedish drugmaker AstraZeneca has gained approval from the US Food and Drug Administration (FDA) to market Zurampic, a treatment for gout, the debilitating form of inflammatory...